8.14
2.05%
-0.17
After Hours:
8.14
Health Catalyst Inc stock is traded at $8.14, with a volume of 270.44K.
It is down -2.05% in the last 24 hours and up +13.21% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$8.31
Open:
$8.27
24h Volume:
270.44K
Relative Volume:
0.50
Market Cap:
$500.09M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-3.0373
EPS:
-2.68
Net Cash Flow:
$-17.32M
1W Performance:
-0.73%
1M Performance:
+13.21%
6M Performance:
+8.10%
1Y Performance:
-19.57%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Apr-12-23 | Initiated | Stephens | Equal-Weight |
Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
Aug-05-22 | Downgrade | Stifel | Buy → Hold |
Apr-14-22 | Initiated | Guggenheim | Buy |
Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
Feb-11-22 | Initiated | Goldman | Buy |
Dec-02-21 | Initiated | Jefferies | Hold |
Oct-14-21 | Initiated | BTIG Research | Buy |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Dec-08-20 | Initiated | Berenberg | Buy |
Jul-14-20 | Initiated | Citigroup | Buy |
Jun-18-20 | Initiated | Stifel | Buy |
Jun-15-20 | Resumed | Evercore ISI | Outperform |
May-15-20 | Initiated | Guggenheim | Buy |
Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
Apr-13-20 | Initiated | SVB Leerink | Outperform |
Apr-02-20 | Initiated | Canaccord Genuity | Buy |
Dec-20-19 | Initiated | Raymond James | Strong Buy |
Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
Aug-19-19 | Initiated | Evercore ISI | Outperform |
Aug-19-19 | Initiated | Goldman | Buy |
Aug-19-19 | Initiated | JP Morgan | Overweight |
Aug-19-19 | Initiated | Piper Jaffray | Overweight |
Aug-19-19 | Initiated | SVB Leerink | Outperform |
Aug-19-19 | Initiated | SunTrust | Buy |
Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Grows By 7.3% - MarketBeat
Healthcare Medical Analytics Market Overall Study Report - openPR
Daventry Group LP Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets (NASDAQ:HCAT) - Seeking Alpha
Inspire Investing LLC Grows Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
First Light Asset Management LLC Grows Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst (NASDAQ:HCAT) Given Overweight Rating at Cantor Fitzgerald - MarketBeat
Expert Outlook: Health Catalyst Through The Eyes Of 7 Analysts - Benzinga
Primecap Management Co. CA Raises Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Healthcare Analytics Market Dynamics: In-Depth Trends, Share - openPR
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 1,324 Shares of Stock - Defense World
Health Catalyst exec sells over $11k in company stock By Investing.com - Investing.com South Africa
Health Catalyst exec sells over $11k in company stock By Investing.com - Investing.com Canada
Health Catalyst exec sells over $11k in company stock - Investing.com India
Health Catalyst exec sells over $11k in company stock By Investing.com - Investing.com UK
Los Angeles Capital Management LLC Has $1.37 Million Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Bought by Acadian Asset Management LLC - Defense World
Improving Outcomes and Lowering the Cost of Care - MarketScale
Health Catalyst CFO sells shares worth over $21,000 - Investing.com
Health Catalyst general counsel sells over $18,000 in company stock - Investing.com
Health Catalyst CFO sells shares worth over $21,000 By Investing.com - Investing.com Australia
Health Catalyst general counsel sells over $18,000 in company stock By Investing.com - Investing.com Australia
Health Catalyst CFO sells shares worth over $21,000 By Investing.com - Investing.com South Africa
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Health Catalyst CFO sells shares worth over $21,000 - Investing.com India
Health Catalyst general counsel sells over $18,000 in company stock - Investing.com India
Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 2,466 Shares - MarketBeat
Health Catalyst general counsel sells over $18,000 in company stock By Investing.com - Investing.com UK
Bruno Lempernesse - DOTmed HealthCare Business News
Bank of New York Mellon Corp Sells 259,263 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst COO sells over $61k in company stock By Investing.com - Investing.com Australia
Health Catalyst executive sells over $54k in company stock By Investing.com - Investing.com Australia
Health Catalyst executive sells over $54k in company stock - Investing.com
Health Catalyst COO sells over $61k in company stock - Investing.com India
Health Catalyst COO sells over $61k in company stock By Investing.com - Investing.com Canada
Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $54,150.00 in Stock - MarketBeat
Health Catalyst COO sells over $61k in company stock By Investing.com - Investing.com UK
Health Catalyst executive sells over $54k in company stock By Investing.com - Investing.com UK
JPMorgan Chase & Co. Increases Health Catalyst (NASDAQ:HCAT) Price Target to $13.00 - MarketBeat
Where are the Opportunities in (HCAT) - Stock Traders Daily
Health Catalyst shares retain buy rating, price target from Canaccord - Investing.com
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon - Healthcare IT Today
Health Catalyst to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Health Catalyst to Participate in Upcoming Investor Conferences - StockTitan
WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite - PR Newswire
Health Catalyst shares target cut, holds rating on execution questions - Investing.com
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts - Benzinga
Health Catalyst (NASDAQ:HCAT) PT Lowered to $11.00 at Piper Sandler - MarketBeat
Baillie Gifford & Co. Lowers Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst finalizes acquisition of Lumeon - Utah Business
Health Catalyst’s (HCAT) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):